Wide-moat GE HealthCare, or GEHC, is a top three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is ...

India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

S&P 500 E-Mini futures (ESH25) are trending down -0.15% this morning, taking a breather at the end of a turbulent week, while ...

Stock markets today will react to US President Donald Trump’s sweeping reciprocal tariff announcements, aimed against almost ...

Tokyo, Japan and Cambridge, UK, 14 February 2025 - Nxera Pharma Co., Ltd. ("Nxera” or "the Company”; TSE 4565) provides an ...

Alnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...

CEO Jan Mikkelsen highlighted 2024 as a pivotal year, with SKYTROFA achieving €200 million in revenue and a 6.5% share of the U.S. growth hormone market. The product now holds 45% of the U.S.